Sterigmatocystin induced apoptosis in human pulmonary cells in vitro

Jinfeng Cui1, Juan Wang1, Shujuan Huang2

  • 1Department of Pathology, The Second Hospital, Hebei Medical University, Shijiazhuang, China.

Insights

Sterigmatocystin (ST) induces apoptosis, a common toxic effect, in lung cancer and bronchial epithelial cells. This study confirms ST

Area of Science:

  • Toxicology
  • Cell Biology
  • Cancer Research

Background:

  • Sterigmatocystin (ST) is a potential carcinogen, mutagen, and teratogen.
  • Previous studies indicated ST induces DNA damage and cell cycle arrest in lung cells.
  • Cell cycle arrest may lead to apoptosis, prompting further investigation into ST's apoptotic effects.

Purpose of the Study:

  • To investigate the effects of Sterigmatocystin (ST) on proliferation and apoptosis in A549 and BEAS-2B cells.
  • To determine if apoptosis is a common in vitro effect of ST across different cell types.

Main Methods:

  • Proliferation was assessed using the MTT assay.
  • Apoptosis was analyzed via flow cytometric analysis (FCM).
  • Western blotting was used to detect changes in apoptosis-related proteins (Bcl-2, Bax, caspase-3).

Main Results:

  • ST treatment inhibited proliferation in both A549 and BEAS-2B cells.
  • FCM analysis revealed increased apoptosis in ST-treated cells.
  • Western blotting showed decreased Bcl-2, increased Bax, and activated caspase-3, indicating apoptosis induction.

Conclusions:

  • Sterigmatocystin (ST) significantly inhibits proliferation and induces apoptosis in lung cancer (A549) and bronchial epithelial (BEAS-2B) cells.
  • The observed down-regulation of Bcl-2, up-regulation of Bax, and activation of caspase-3 support ST's role in inducing apoptosis.
  • Inducing apoptosis appears to be a common in vitro toxic effect of ST across various cell types.

Related Concept Videos